199 related articles for article (PubMed ID: 11518779)
1. Glycosylation of circulating IgA in patients with IgA nephropathy modulates proliferation and apoptosis of mesangial cells.
Amore A; Cirina P; Conti G; Brusa P; Peruzzi L; Coppo R
J Am Soc Nephrol; 2001 Sep; 12(9):1862-1871. PubMed ID: 11518779
[TBL] [Abstract][Full Text] [Related]
2. Aberrant glycosylation in IgA nephropathy (IgAN).
Coppo R; Amore A
Kidney Int; 2004 May; 65(5):1544-7. PubMed ID: 15086888
[TBL] [Abstract][Full Text] [Related]
3. Integrin expression and IgA nephropathy: in vitro modulation by IgA with altered glycosylation and macromolecular IgA.
Peruzzi L; Amore A; Cirina P; Trusolino L; Basso G; Ricotti E; Emancipator SN; Marchisio PC; Coppo R
Kidney Int; 2000 Dec; 58(6):2331-40. PubMed ID: 11115067
[TBL] [Abstract][Full Text] [Related]
4. Aberrantly glycosylated serum IgA1 are closely associated with pathologic phenotypes of IgA nephropathy.
Xu LX; Zhao MH
Kidney Int; 2005 Jul; 68(1):167-72. PubMed ID: 15954905
[TBL] [Abstract][Full Text] [Related]
5. The glycans deficiencies of macromolecular IgA1 is a contributory factor of variable pathological phenotypes of IgA nephropathy.
Xu LX; Yan Y; Zhang JJ; Zhang Y; Zhao MH
Clin Exp Immunol; 2005 Dec; 142(3):569-75. PubMed ID: 16297170
[TBL] [Abstract][Full Text] [Related]
6. Enzymatic sialylation of IgA1 O-glycans: implications for studies of IgA nephropathy.
Takahashi K; Raska M; Stuchlova Horynova M; Hall SD; Poulsen K; Kilian M; Hiki Y; Yuzawa Y; Moldoveanu Z; Julian BA; Renfrow MB; Novak J
PLoS One; 2014; 9(2):e99026. PubMed ID: 24918438
[TBL] [Abstract][Full Text] [Related]
7. Recognition of galactose-deficient O-glycans in the hinge region of IgA1 by N-acetylgalactosamine-specific snail lectins: a comparative binding study.
Gomes MM; Suzuki H; Brooks MT; Tomana M; Moldoveanu Z; Mestecky J; Julian BA; Novak J; Herr AB
Biochemistry; 2010 Jul; 49(27):5671-82. PubMed ID: 20507092
[TBL] [Abstract][Full Text] [Related]
8. Increased sialylation of polymeric lambda-IgA1 in patients with IgA nephropathy.
Leung JC; Tang SC; Chan DT; Lui SL; Lai KN
J Clin Lab Anal; 2002; 16(1):11-9. PubMed ID: 11835525
[TBL] [Abstract][Full Text] [Related]
9. Binding capacity and pathophysiological effects of IgA1 from patients with IgA nephropathy on human glomerular mesangial cells.
Wang Y; Zhao MH; Zhang YK; Li XM; Wang HY
Clin Exp Immunol; 2004 Apr; 136(1):168-75. PubMed ID: 15030528
[TBL] [Abstract][Full Text] [Related]
10. IgA1-containing immune complexes in IgA nephropathy differentially affect proliferation of mesangial cells.
Novak J; Tomana M; Matousovic K; Brown R; Hall S; Novak L; Julian BA; Wyatt RJ; Mestecky J
Kidney Int; 2005 Feb; 67(2):504-13. PubMed ID: 15673298
[TBL] [Abstract][Full Text] [Related]
11. N-acetylgalactosaminide α2,6-sialyltransferase II is a candidate enzyme for sialylation of galactose-deficient IgA1, the key autoantigen in IgA nephropathy.
Stuchlova Horynova M; Vrablikova A; Stewart TJ; Takahashi K; Czernekova L; Yamada K; Suzuki H; Julian BA; Renfrow MB; Novak J; Raska M
Nephrol Dial Transplant; 2015 Feb; 30(2):234-8. PubMed ID: 25281698
[TBL] [Abstract][Full Text] [Related]
12. Increased sialylation of polymeric immunoglobulin A1: mechanism of selective glomerular deposition in immunoglobulin A nephropathy?
Leung JC; Poon PY; Lai KN
J Lab Clin Med; 1999 Feb; 133(2):152-60. PubMed ID: 9989767
[TBL] [Abstract][Full Text] [Related]
13. Glycosylation profile of differently charged IgA1 and their binding characteristics to cultured mesangial cells in IgA nephropathy.
Leung JC; Chan LY; Tang SC; Tam PC; Fenn J; Lai KN
Nephron Exp Nephrol; 2007; 107(3):e107-18. PubMed ID: 17957128
[TBL] [Abstract][Full Text] [Related]
14. Role of aberrant glycosylation of IgA1 molecules in the pathogenesis of IgA nephropathy.
Mestecky J; Tomana M; Moldoveanu Z; Julian BA; Suzuki H; Matousovic K; Renfrow MB; Novak L; Wyatt RJ; Novak J
Kidney Blood Press Res; 2008; 31(1):29-37. PubMed ID: 18182777
[TBL] [Abstract][Full Text] [Related]
15. IgA1 immune complexes from pediatric patients with IgA nephropathy activate cultured human mesangial cells.
Novak J; Raskova Kafkova L; Suzuki H; Tomana M; Matousovic K; Brown R; Hall S; Sanders JT; Eison TM; Moldoveanu Z; Novak L; Novak Z; Mayne R; Julian BA; Mestecky J; Wyatt RJ
Nephrol Dial Transplant; 2011 Nov; 26(11):3451-7. PubMed ID: 21828345
[TBL] [Abstract][Full Text] [Related]
16. Differential glycosylation of polymeric and monomeric IgA: a possible role in glomerular inflammation in IgA nephropathy.
Oortwijn BD; Roos A; Royle L; van Gijlswijk-Janssen DJ; Faber-Krol MC; Eijgenraam JW; Dwek RA; Daha MR; Rudd PM; van Kooten C
J Am Soc Nephrol; 2006 Dec; 17(12):3529-39. PubMed ID: 17050773
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of IgA1 O-glycosylation in Henoch-Schönlein Purpura Nephritis Using Mass Spectrometry.
Nakazawa S; Imamura R; Kawamura M; Kato T; Abe T; Iwatani H; Yamanaka K; Uemura M; Kishikawa H; Nishimura K; Tajiri M; Wada Y; Nonomura N
Transplant Proc; 2019 Jun; 51(5):1481-1487. PubMed ID: 31084922
[TBL] [Abstract][Full Text] [Related]
18. Mesangial expression of angiotensin II receptor in IgA nephropathy and its regulation by polymeric IgA1.
Lai KN; Chan LY; Tang SC; Tsang AW; Li FF; Lam MF; Lui SL; Leung JC
Kidney Int; 2004 Oct; 66(4):1403-16. PubMed ID: 15458433
[TBL] [Abstract][Full Text] [Related]
19. IgA nephropathy and Henoch-Schoenlein purpura nephritis: aberrant glycosylation of IgA1, formation of IgA1-containing immune complexes, and activation of mesangial cells.
Novak J; Moldoveanu Z; Renfrow MB; Yanagihara T; Suzuki H; Raska M; Hall S; Brown R; Huang WQ; Goepfert A; Kilian M; Poulsen K; Tomana M; Wyatt RJ; Julian BA; Mestecky J
Contrib Nephrol; 2007; 157():134-8. PubMed ID: 17495451
[TBL] [Abstract][Full Text] [Related]
20. Pathogenetic significance of aberrant glycosylation of IgA1 in IgA nephropathy.
Narita I; Gejyo F
Clin Exp Nephrol; 2008 Oct; 12(5):332-338. PubMed ID: 18404247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]